Published in J Neural Transm (Vienna) on May 14, 2008
Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain (2009) 0.96
Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. J Headache Pain (2010) 0.89
Association of brain-derived neurotrophic factor and nerve growth factor gene polymorphisms with susceptibility to migraine. Neuropsychiatr Dis Treat (2016) 0.78
The association between brain-derived neurotrophic factor gene polymorphism and migraine: a meta-analysis. J Headache Pain (2017) 0.76
Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism Impacts on Migraine Susceptibility: A Meta-analysis of Case-Control Studies. Front Neurol (2017) 0.75
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell (2003) 12.50
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med (2004) 4.39
Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci (2004) 3.47
Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci (2006) 3.44
Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science (1990) 2.91
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature (1991) 2.70
Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry (2007) 2.55
A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology (2002) 2.07
BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry (2005) 2.00
Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci (1999) 1.77
Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett (1996) 1.64
Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci (1994) 1.54
Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci (1995) 1.52
Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-D-aspartate receptor subunit 1. Proc Natl Acad Sci U S A (1997) 1.47
Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons. J Neurochem (2006) 1.14
Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets (2004) 1.13
Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int (2000) 1.04
Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia (2006) 0.98
A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology (2005) 0.96
Brain derived neurotrophic factor induction of N-methyl-D-aspartate receptor subunit NR2A expression in cultured rat cortical neurons. Neurosci Lett (1998) 0.84
Nerve growth factor and chronic daily headache: a potential implication for therapy. Expert Rev Neurother (2004) 0.78
An adenosine A2A receptor gene haplotype is associated with migraine with aura. Cephalalgia (2007) 0.77
Functional polymorphisms of the 5-HT1A and 5-HT1B receptor are associated with clinical symptoms in migraineurs. J Neural Transm (Vienna) (2007) 0.77
NeuPSIG guidelines on neuropathic pain assessment. Pain (2010) 4.04
Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia. Pain (2015) 3.82
Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci (2003) 2.89
Small fibre pathology in patients with fibromyalgia syndrome. Brain (2013) 2.72
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain (2010) 2.35
Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology (2012) 2.09
Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials. Pain (2009) 1.93
Chronically infused intrathecal morphine in dogs. Anesthesiology (2003) 1.93
Differential expression patterns of cytokines in complex regional pain syndrome. Pain (2007) 1.91
Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp Neurol (2012) 1.81
TNF-α in CRPS and 'normal' trauma--significant differences between tissue and serum. Pain (2010) 1.74
Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum (2006) 1.64
Functional and structural nerve fiber findings in heterozygote patients with Fabry disease. Pain (2009) 1.62
Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA (2009) 1.58
Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months. Pain (2013) 1.52
Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol (2010) 1.41
Intravenous immunoglobulin to fight complex regional pain syndromes: hopes and doubts. Ann Intern Med (2010) 1.38
Differential expression of cytokines in painful and painless neuropathies. Neurology (2007) 1.38
Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol (2011) 1.37
A key role for gp130 expressed on peripheral sensory nerves in pathological pain. J Neurosci (2009) 1.37
Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci (2003) 1.32
Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway. J Neurosci (2008) 1.31
T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol (2006) 1.30
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord (2011) 1.30
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood (2005) 1.27
Mode of action of cytokines on nociceptive neurons. Exp Brain Res (2009) 1.26
Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophr Res (2012) 1.24
Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy. J Peripher Nerv Syst (2011) 1.15
Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain (2010) 1.15
Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain (2003) 1.15
Wallerian degeneration after crush injury of rat sciatic nerve increases endo- and epineurial tumor necrosis factor-alpha protein. Neurosci Lett (2004) 1.14
The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J Neurosci (2011) 1.14
Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis. Arthritis Care Res (Hoboken) (2011) 1.14
Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain Behav Immun (2007) 1.13
Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome. Eur J Pain (2008) 1.13
Cutaneous neuropathy in Parkinson's disease: a window into brain pathology. Acta Neuropathol (2014) 1.12
Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve (2008) 1.12
TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain (2007) 1.11
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol (2011) 1.11
Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J Neurosci (2002) 1.08
Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain (2013) 1.08
Physiological properties of spinal lamina II GABAergic neurons in mice following peripheral nerve injury. J Physiol (2006) 1.08
Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch. J Am Soc Nephrol (2014) 1.07
Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci Lett (2008) 1.06
Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci (2003) 1.05
Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. Eur J Pain (2007) 1.05
Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline. Ger Med Sci (2008) 1.03
Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. Int J Neuropsychopharmacol (2006) 1.02
Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury. J Neurosci (2012) 1.02
Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch Neurol (2004) 1.02
Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat. Exp Neurol (2004) 1.01
Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur J Neurosci (2004) 1.00
Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice. Mol Pain (2010) 1.00
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study). J Peripher Nerv Syst (2013) 1.00
The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs (2012) 1.00
Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA). Thromb Haemost (2006) 0.99
A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome. Arthritis Rheum (2008) 0.98
Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Exp Neurol (2005) 0.97
Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int J Neuropsychopharmacol (2004) 0.97
Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther (2014) 0.96
The brain-specific protein MLC1 implicated in megalencephalic leukoencephalopathy with subcortical cysts is expressed in glial cells in the murine brain. Glia (2003) 0.96
Human stiff-person syndrome IgG induces anxious behavior in rats. PLoS One (2011) 0.95
Transient opening of the perineurial barrier for analgesic drug delivery. Proc Natl Acad Sci U S A (2012) 0.95
Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF. Neuropharmacology (2007) 0.95
Fighting off pain with resolvins. Nat Med (2010) 0.95
Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol (2003) 0.95
Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating. Proc Natl Acad Sci U S A (2012) 0.94
The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence. Mol Neurobiol (2009) 0.94
Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology (2010) 0.94
Anticytokine therapy in neuropathic pain management. Expert Rev Neurother (2007) 0.93
Sensorimotor gating of schizophrenia patients depends on Catechol O-methyltransferase Val158Met polymorphism. Schizophr Bull (2008) 0.93
Characterization of pain in fabry disease. Clin J Pain (2014) 0.92
Analysis of myelinated fibers in human skin biopsies of patients with neuropathies. J Neurol (2012) 0.92
Increased pain and neurogenic inflammation in mice deficient of neutral endopeptidase. Neurobiol Dis (2008) 0.91
Magnetic resonance neurography for the diagnosis of extrapelvic sciatic endometriosis. Fertil Steril (2010) 0.91
Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing. J Peripher Nerv Syst (2006) 0.91
Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: comparison of different diagnostic modalities. Eur J Pain (2008) 0.91
Copy number variants in German patients with schizophrenia. PLoS One (2013) 0.91
Altered pain behavior and regeneration after nerve injury in TNF receptor deficient mice. J Peripher Nerv Syst (2006) 0.91
Sensorimotor gating of schizophrenia patients is influenced by 5-HT2A receptor polymorphisms. Biol Psychiatry (2008) 0.91
Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients. Neuropsychobiology (2011) 0.91
Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge. Am J Med (2010) 0.90
Early cytokine gene expression in mouse CNS after peripheral nerve lesion. Neurosci Lett (2008) 0.90
Assessment of nerve degeneration by gadofluorine M-enhanced magnetic resonance imaging. Ann Neurol (2005) 0.90
Deficiency of the negative immune regulator B7-H1 enhances inflammation and neuropathic pain after chronic constriction injury of mouse sciatic nerve. Exp Neurol (2010) 0.89
αCaMKII autophosphorylation controls the establishment of alcohol drinking behavior. Neuropsychopharmacology (2013) 0.89
Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity. Neuropsychopharmacology (2005) 0.89
Etiology of small-fiber neuropathy. J Peripher Nerv Syst (2009) 0.89
Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev (2013) 0.88
Epidermal innervation in type 1 diabetic patients: a 2.5-year prospective study after simultaneous pancreas/kidney transplantation. Diabetes Care (2008) 0.88
Psychophysics, flare, and neurosecretory function in human pain models: capsaicin versus electrically evoked pain. J Pain (2007) 0.88
Correlation of epidermal nerve fiber density with pain-related evoked potentials in HIV neuropathy. Pain (2007) 0.88
Reduced thermal hyperalgesia and enhanced peripheral nerve injury after hind paw inflammation in mice lacking the serotonin-transporter. Eur J Pain (2008) 0.88
Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study. BMC Neurol (2013) 0.87
Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology (Oxford) (2010) 0.87